cysteine has been researched along with fluorouracil in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Kawabata, N; Nakashima, T; Ohno, H; Yano, K | 1 |
| Araki, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
| Hoshi, A; Iigo, M; Kitagawa, H | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
| Hoshi, A; Iigo, M | 1 |
| Oshima, T; Tsukiyama, I | 1 |
| Franke, HD | 1 |
| Schmerold, I; Tempel, K; Winkle, J; Wulffius-Kock, M | 1 |
| Burba-Anczewska, I; Danysz, A; Pniewska, A; Pragłowski, T; Wierzba, K; Wutkiewicz, M | 1 |
| Danysz, A; Pniewska, A; Pragłowski, T; Wierzba, K; Wutkiewicz, M | 1 |
| Kawabata, N; Kitagawa, H; Kuwamura, T; Satoh, T; Sugiyama, S | 1 |
| Burba-Anczewska, I; Danysz, A; Kłosiewicz, S; Pniewska, A; Wierzba, K | 1 |
| Busse, E; Kornhuber, B; Zimmer, G | 1 |
| Ha, H; Jung, H; Seong, HA | 1 |
| Kaul, A; Mishra, BJ; Trivedi, P | 1 |
| Aragão, KS; Brito, GAC; Freire, GE; Freitas, MR; Leitão, RFC; Martins, CDS; Silva, VCD; Wanderley, CWS | 1 |
| Qiao, LL; Yang, X; Yao, WJ; Zhang, ZQ; Zhao, MX | 1 |
| Bu, D; Chen, S; Guo, S; Liu, Y; Pan, Y; Wang, P; Wang, X; Yue, T; Zhu, J | 1 |
| Mohamed, MZ; Mohammed, HH | 1 |
| Banerji, B; Ghosh, S; Nag, S; Saha, KD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and fluorouracil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for cysteine and fluorouracil
| Article | Year |
|---|---|
Effect of L-cysteine on plasma concentration and urinary excretion of 1-(tetrahydro-2-furanyl)-5-fluorouracil metabolites.
Topics: Animals; Cysteine; Fluorouracil; Kidney Tubules; Male; Rats; Rats, Inbred Strains; Tegafur | 1991 |
Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cysteine; Drug Synergism; Floxuridine; Fluorouracil; Humans; Injections, Intravenous; Lung Neoplasms; Male; Mice | 1989 |
Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Cysteine; Cystine; Drug Synergism; Fluorouracil; Male; Mice; Mice, Inbred Strains; Tegafur | 1986 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cysteine; Drug Evaluation, Preclinical; Drug Synergism; Fluorouracil; Male; Mice; Tegafur | 1987 |
Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteine.
Topics: Adenocarcinoma; Animals; Cysteine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; Metabolic Clearance Rate; Mice; RNA, Neoplasm | 1986 |
[Studies of cancer radiotherapy by combined use of radioprotectors and a radiosensitizer].
Topics: Animals; beta-Aminoethyl Isothiourea; Cysteine; Fluorouracil; Male; Mercaptoethylamines; Mice; Neoplasms, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents; Rats | 1973 |
[Use of radiation sensitizing agents in radiotherapy].
Topics: Acetates; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Choline; Cysteine; Fluorouracil; Hematoporphyrins; Humans; Hydrogen Peroxide; Mitosis; Nitrogen Oxides; Oxygen; Periodicity; Quinones; Radiation-Sensitizing Agents; Radiotherapy; Steroids; Thyroid Hormones; Trypan Blue; Urethane; Uridine; Vitamins | 1972 |
[Semiconservative and unscheduled DNA-synthesis of rat thymocytes under the influence of some radioprotecting and radiosensitizing agents (author's transl)].
Topics: Acetophenones; Animals; beta-Aminoethyl Isothiourea; Bleomycin; Cysteamine; Cysteine; Cytarabine; Ditiocarb; DNA; Doxorubicin; Ethidium; Ethylmaleimide; Female; Fluorouracil; Glutathione; Mercaptoethanol; Metronidazole; Nitrofurazone; Radiation-Protective Agents; Radiation-Sensitizing Agents; Rats; T-Lymphocytes; Tiopronin | 1982 |
Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
Topics: Animals; Cysteine; Drug Synergism; Fluorouracil; Glutathione; Insulin; Leukemia L1210; Mercaptopurine; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Sarcoma 180; Sulfhydryl Compounds | 1984 |
The effect of some sulfhydryl compounds on the toxicity of 5-fluorouracil and 6-mercaptopurine in laboratory animals.
Topics: Animals; Cysteine; Drug Interactions; Fluorouracil; Glutathione; Insulin; Male; Mercaptopurine; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains | 1984 |
Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
Topics: Absorption; Animals; Antineoplastic Agents; Biotransformation; Cysteine; Fluorouracil; Kinetics; Lethal Dose 50; Male; Mice; Microsomes, Liver; Rats; Rats, Inbred Strains; Tegafur | 1983 |
The effect of sulfhydryl compounds on 5-fluorouracil toxicity and distribution.
Topics: Animals; Cysteine; Fluorouracil; Glutathione; Kinetics; Lethal Dose 50; Male; Mesna; Mice; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1983 |
Intracellular changes of HeLa cells after single or repeated treatment with cytostatics.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cell Membrane; Cisplatin; Cysteine; Doxorubicin; Fluorouracil; Glutathione; HeLa Cells; Humans; Membrane Fluidity; Membranes; Protein Kinase C | 1993 |
Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity.
Topics: Active Transport, Cell Nucleus; Apoptosis; Cell Line; Cysteine; Doxorubicin; Fluorouracil; Gene Expression Regulation; Humans; Macrophage Migration-Inhibitory Factors; Mutation; Protein Binding; RNA Interference; Transcription, Genetic; Tumor Suppressor Protein p53 | 2008 |
L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Cysteine; Drug Carriers; Drug Compounding; Drug Delivery Systems; Fluorouracil; Half-Life; Lung; Male; Metabolic Clearance Rate; Mice, Inbred BALB C; Nanoparticles; Particle Size; Poloxamer; Polyesters; Rats; Solubility; Surface Properties; Tissue Distribution | 2015 |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil 1.
Topics: Animals; Cricetinae; Cysteine; Cytokines; Disease Models, Animal; Fluorouracil; Immunohistochemistry; Leukotrienes; Male; Stomatitis | 2017 |
The Biological Activity Research of the Nano-Drugs Based on 5-Fluorouracil-Modified Quantum Dots.
Topics: Antimetabolites, Antineoplastic; Cell Proliferation; Cysteine; Drug Carriers; Ethylenediamines; Fluorouracil; HeLa Cells; Hep G2 Cells; Humans; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Quantum Dots; Reactive Oxygen Species; Spectrophotometry, Ultraviolet | 2020 |
Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells.
Topics: Amino Acid Transport System y+; Animals; Cell Line, Tumor; Colonic Neoplasms; Cysteine; Deubiquitinating Enzymes; Disease Models, Animal; Fluorouracil; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Sulfide; Immunohistochemistry; Mice; Models, Biological; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Synthetic Lethal Mutations; Tissue Array Analysis | 2021 |
Rupatadine protects the intestinal mucosa from injury by 5-flurouracil via modulation of inflammation, apoptosis and intestinal permeability.
Topics: Animals; Apoptosis; Aspartic Acid Proteases; Carboxymethylcellulose Sodium; Caspase 3; Cysteine; Fluorouracil; Glutathione; Histamine; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Irritants; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Permeability; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2022 |
S-Benzyl cysteine based cyclic dipeptide super hydrogelator: Enhancing efficacy of an anticancer drug via sustainable release.
Topics: Antineoplastic Agents; Cysteine; Dipeptides; Fluorouracil; Humans; Hydrogels; Peptides; Spectroscopy, Fourier Transform Infrared | 2022 |